scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1050047961 |
P356 | DOI | 10.1007/S13277-014-1612-Y |
P698 | PubMed publication ID | 24430362 |
P5875 | ResearchGate publication ID | 259766893 |
P50 | author | Spyridon Christodoulou | Q47503577 |
Andreas Scorilas | Q40005217 | ||
Christos K. Kontos | Q41025112 | ||
Iordanis N. Papadopoulos | Q42907857 | ||
P2093 | author name string | Dimitra K Alexopoulou | |
P2860 | cites work | Proteinase-activated receptors, targets for kallikrein signaling | Q24298638 |
Immunofluorometric quantitation and histochemical localisation of kallikrein 6 protein in ovarian cancer tissue: a new independent unfavourable prognostic biomarker | Q24648238 | ||
Nonparametric Estimation from Incomplete Observations | Q25938997 | ||
Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method | Q25938999 | ||
The genetic basis of colorectal cancer: insights into critical pathways of tumorigenesis | Q28138414 | ||
Human and mouse proteases: a comparative genomic approach | Q28184208 | ||
ASCO 2006 update of recommendations for the use of tumor markers in gastrointestinal cancer | Q28270163 | ||
The emerging roles of human tissue kallikreins in cancer | Q28290701 | ||
PAR1-type thrombin receptor stimulates migration and matrix adhesion of human colon carcinoma cells by a PKCepsilon-dependent mechanism | Q28294688 | ||
The role of gelatinases in colorectal cancer progression and metastasis | Q28297496 | ||
In silico analysis of the human kallikrein gene 6. | Q33210507 | ||
Identification of endogenous control genes for normalisation of real-time quantitative PCR data in colorectal cancer | Q33528155 | ||
Kallikrein-related peptidase 4: a new activator of the aberrantly expressed protease-activated receptor 1 in colon cancer cells | Q33703798 | ||
Kallikrein 6 signals through PAR1 and PAR2 to promote neuron injury and exacerbate glutamate neurotoxicity | Q33898352 | ||
Upregulation of tissue kallikrein, kinin B1 receptor, and kinin B2 receptor in mast and giant cells infiltrating oesophageal squamous cell carcinoma | Q43010073 | ||
Prognostic value of kallikrein-related peptidase 6 protein expression levels in advanced ovarian cancer evaluated by automated quantitative analysis (AQUA). | Q43418010 | ||
Increased expression of protease M in ovarian tumors. | Q43508961 | ||
Kallikrein-related peptidase 4 (KLK4) mRNA predicts short-term relapse in colorectal adenocarcinoma patients. | Q45909283 | ||
A Case–Control Study of Screening Sigmoidoscopy and Mortality from Colorectal Cancer | Q46030054 | ||
Substrate specificity of human kallikrein 6: salt and glycosaminoglycan activation effects | Q46830854 | ||
Clinical significance of kallikrein-related peptidase 7 (KLK7) in colorectal cancer | Q50357080 | ||
Kallikrein-related peptidases (KLKs) in gastrointestinal cancer: mechanistic and clinical aspects. | Q53257460 | ||
Human kallikrein 6: a new potential serum biomarker for uterine serous papillary cancer. | Q53679668 | ||
Prognostic implications of the immunohistochemical expression of human kallikreins 5, 6, 10 and 11 in renal cell carcinoma. | Q53805326 | ||
Clinical significance of human kallikrein gene 6 messenger RNA expression in colorectal cancer. | Q54669080 | ||
Evaluation and prognostic significance of human tissue kallikrein-related peptidase 6 (KLK6) in colorectal cancer | Q57940755 | ||
Human Kallikrein 6 Degrades Extracellular Matrix Proteins and May Enhance the Metastatic Potential of Tumour Cells | Q57942209 | ||
Human Kallikrein 6 (hK6): A New Potential Serum Biomarker for Diagnosis and Prognosis of Ovarian Carcinoma | Q57942345 | ||
Human kallikrein 6 (zyme/protease M/neurosin): a new serum biomarker of ovarian carcinoma | Q57942914 | ||
KLK11 mRNA expression predicts poor disease-free and overall survival in colorectal adenocarcinoma patients | Q62606052 | ||
Clinical significance of kallikrein-related peptidase (KLK10) mRNA expression in colorectal cancer | Q62606054 | ||
Parallel overexpression and clinical significance of kallikrein-related peptidases 7 and 14 (KLK7 & KLK14) in colon cancer | Q62606061 | ||
Clinical significance of human kallikrein 10 gene expression in colorectal cancer and gastric cancer | Q80157928 | ||
X-tile: a new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization | Q80980462 | ||
Kallikrein 6 induces E-cadherin shedding and promotes cell proliferation, migration, and invasion | Q81098053 | ||
Genomic organization of the human kallikrein gene family on chromosome 19q13.3-q13.4. | Q33919333 | ||
Carcinoembryonic antigen as a marker for colorectal cancer: is it clinically useful? | Q33939899 | ||
Proteinase-activated receptors. | Q33947141 | ||
Expression and function of the kallikrein-related peptidase 6 in the human melanoma microenvironment | Q35350228 | ||
Kallikrein-related peptidase 14 acts on proteinase-activated receptor 2 to induce signaling pathway in colon cancer cells | Q35474479 | ||
Aberrant Expression and Activation of the Thrombin Receptor Protease-Activated Receptor-1 Induces Cell Proliferation and Motility in Human Colon Cancer Cells | Q35749110 | ||
High kallikrein-related peptidase 6 in non-small cell lung cancer cells: an indicator of tumour proliferation and poor prognosis | Q35893466 | ||
Kallikrein 6 is a novel molecular trigger of reactive astrogliosis. | Q35910761 | ||
Physiology and pathophysiology of proteinase-activated receptors (PARs): PAR-2-mediated proliferation of colon cancer cell. | Q36012117 | ||
Lymph node tissue kallikrein-related peptidase 6 mRNA: a progression marker for colorectal cancer | Q36075255 | ||
Proteinase-mediated cell signalling: targeting proteinase-activated receptors (PARs) by kallikreins and more | Q36519368 | ||
Transcriptional upregulation of human tissue kallikrein 6 in ovarian cancer: clinical and mechanistic aspects. | Q36609685 | ||
Co-expression of KLK6 and KLK10 as prognostic factors for survival in pancreatic ductal adenocarcinoma | Q36965062 | ||
Prostatic trypsin-like kallikrein-related peptidases (KLKs) and other prostate-expressed tryptic proteinases as regulators of signalling via proteinase-activated receptors (PARs). | Q37216570 | ||
Protease-activated receptor dependent and independent signaling by kallikreins 1 and 6 in CNS neuron and astroglial cell lines | Q37217423 | ||
The use of kallikrein-related peptidases as adjuvant prognostic markers in colorectal cancer | Q37228450 | ||
KLK6 and KLK13 predict tumor recurrence in epithelial ovarian carcinoma | Q37400530 | ||
New insights into the functional mechanisms and clinical applications of the kallikrein-related peptidase family | Q37453804 | ||
Kallikrein-related peptidase genes as promising biomarkers for prognosis and monitoring of human malignancies | Q37714914 | ||
Kallikrein-related peptidases in prostate, breast, and ovarian cancers: from pathobiology to clinical relevance | Q38002824 | ||
Kallikrein-related peptidases (KLKs): a gene family of novel cancer biomarkers | Q38055059 | ||
Up-regulation and clinical significance of serine protease kallikrein 6 in colon cancer | Q39527940 | ||
The kallikrein-related peptidase 13 (KLK13) gene is substantially up-regulated after exposure of gastric cancer cells to antineoplastic agents. | Q39558472 | ||
Global cancer transitions according to the Human Development Index (2008-2030): a population-based study. | Q39608822 | ||
Clinical significance of human kallikrein7 gene expression in colorectal cancer | Q39693773 | ||
Expression analysis and clinical evaluation of kallikrein-related peptidase 10 (KLK10) in colorectal cancer | Q39761179 | ||
Kallikrein 6 is a mediator of K-RAS-dependent migration of colon carcinoma cells | Q39961341 | ||
Caveolin-1-mediated expression and secretion of kallikrein 6 in colon cancer cells | Q40011698 | ||
Multiple mechanisms underlie the aberrant expression of the human kallikrein 6 gene in breast cancer | Q40262755 | ||
Normalizing genes for quantitative RT-PCR in differentiating human intestinal epithelial cells and adenocarcinomas of the colon | Q40332571 | ||
Downregulation of human kallikrein 10 (KLK10/NES1) by CpG island hypermethylation in breast, ovarian and prostate cancers | Q40357075 | ||
Clinicopathologic and biological significance of kallikrein 6 overexpression in human gastric cancer | Q40366077 | ||
Protease-activated receptor 2 in colon cancer: trypsin-induced MAPK phosphorylation and cell proliferation are mediated by epidermal growth factor receptor transactivation | Q40580473 | ||
P433 | issue | 5 | |
P921 | main subject | biomarker | Q864574 |
P304 | page(s) | 4673-4685 | |
P577 | publication date | 2014-01-16 | |
P1433 | published in | Tumor Biology | Q15757842 |
P1476 | title | Kallikrein-related peptidase-6 (KLK6) mRNA expression is an independent prognostic tissue biomarker of poor disease-free and overall survival in colorectal adenocarcinoma | |
P478 | volume | 35 |
Q56888917 | A potent, proteolysis-resistant inhibitor of kallikrein-related peptidase 6 (KLK6) for cancer therapy, developed by combinatorial engineering |
Q90702145 | Alternative Splicing Detection Tool-a novel PERL algorithm for sensitive detection of splicing events, based on next-generation sequencing data analysis |
Q41823848 | Detection of Biomarkers with Solid-Phase Proximity Ligation Assay in Patients with Colorectal Cancer |
Q54976872 | Diagnostic and prognostic biomarker potential of kallikrein family genes in different cancer types. |
Q88255485 | Discovery of novel transcripts of the human tissue kallikrein (KLK1) and kallikrein-related peptidase 2 (KLK2) in human cancer cells, exploiting Next-Generation Sequencing technology |
Q92347394 | Identification of Prognostic Biomarkers and Drugs Targeting Them in Colon Adenocarcinoma: A Bioinformatic Analysis |
Q26771266 | Involvement of Kallikrein-Related Peptidases in Normal and Pathologic Processes |
Q47164608 | Molecular cloning of novel transcripts of human kallikrein-related peptidases 5, 6, 7, 8 and 9 (KLK5 - KLK9), using Next-generation sequencing |
Q47096307 | Non-coding RNAs profiling in head and neck cancers. |
Q90702126 | Non-coding RNAs: the riddle of the transcriptome and their perspectives in cancer |
Q28543174 | Overexpression of lipocalins and pro-inflammatory chemokines and altered methylation of PTGS2 and APC2 in oral squamous cell carcinomas induced in rats by 4-nitroquinoline-1-oxide |
Q35732225 | Prognostic significance of multiple kallikreins in high-grade astrocytoma |
Q90702137 | Quantitative analysis and study of the mRNA expression levels of apoptotic genes BCL2, BAX and BCL2L12 in the articular cartilage of an animal model of osteoarthritis |
Q37711929 | Transcriptome reveals the overexpression of a kallikrein gene cluster (KLK1/3/7/8/12) in the Tibetans with high altitude-associated polycythemia |
Q50203849 | miR-15a-5p, A Novel Prognostic Biomarker, Predicting Recurrent Colorectal Adenocarcinoma |
Search more.